E C Keystone Selected Research

E C Keystone Research Topics

19	Rheumatoid Arthritis 01/2021 - 11/2000
9	Rheumatic Diseases (Rheumatism) 04/2012 - 11/2002
6	Necrosis 09/2020 - 11/2004
2	Arthritis (Polyarthritis) 01/2021 - 01/2013
2	Infections 07/2009 - 11/2000
1	Hypertension (High Blood Pressure) 11/2019
1	Obesity 11/2019
1	Glucose Intolerance 11/2019
1	Ankylosing Spondylitis 01/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016
1	Pain (Aches) 10/2015
1	Wounds and Injuries (Trauma) 09/2007
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2005
1	Giant Cell Arteritis (Horton Disease) 11/2004
1	Polyarteritis Nodosa (Periarteritis Nodosa) 11/2004
1	Behcet Syndrome (Behcet's Syndrome) 11/2004
1	Sarcoidosis (Schaumann Disease) 11/2004
1	Sjogren's Syndrome (Sjogren Syndrome) 11/2004
1	Hepatitis C 11/2004
1	Vasculitis (Vasculitides) 11/2004
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 11/2004
1	Churg-Strauss Syndrome (Allergic Angiitis) 11/2004

14	Biological ProductsIBA 04/2012 - 11/2002
6	Methotrexate (Mexate)FDA LinkGeneric 01/2011 - 11/2000
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2005 - 11/2000
3	ametantrone (HAQ)IBA 01/2021 - 01/2013
3	Infliximab (Remicade)FDA Link 01/2016 - 09/2003
3	Rituximab (Mabthera)FDA Link 02/2007 - 05/2005
2	Biosimilar PharmaceuticalsIBA 09/2020 - 01/2016
2	Adalimumab (Humira)FDA Link 06/2006 - 09/2003
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2005 - 11/2004
2	Etanercept (Enbrel)FDA Link 11/2004 - 11/2000
1	Antirheumatic Agents (DMARD)IBA 01/2021
1	HDL CholesterolIBA 11/2019
1	Triglycerides (Triacylglycerol)IBA 11/2019
1	Immunomodulating AgentsIBA 01/2016
1	CT-P13IBA 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	Rheumatoid FactorIBA 01/2013
1	Certolizumab Pegol FDA Link 01/2011
1	golimumab FDA Link 06/2009
1	RNA (Ribonucleic Acid)IBA 09/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2005
1	Tumor Necrosis Factor InhibitorsIBA 11/2004